We are a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies.
$14.00 - $16.00
November 7, 2019
LEERINK SWANN & COMPANY
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Centogene B.V. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253